AGP Picks
View all

Wellness Daily Nauru
Provided by AGP

Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 13, 2026

InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026

InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
May 13, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 13, 2026

Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update

Indeterminate GlobeNewswire
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 13, 2026

BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Indeterminate GlobeNewswire
Altimmune Announces First Quarter 2026 Financial Results and Business Update
May 13, 2026

Altimmune Announces First Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
May 13, 2026

Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress

Indeterminate GlobeNewswire
Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
May 13, 2026

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
May 13, 2026

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

Indeterminate GlobeNewswire
Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline
May 13, 2026

Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline

Indeterminate GlobeNewswire
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
May 13, 2026

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 
May 13, 2026

Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 

Indeterminate GlobeNewswire
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026

BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 13, 2026

Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Indeterminate GlobeNewswire
Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy
May 13, 2026

Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy

Indeterminate GlobeNewswire
Andera Partners Leads $20 Million Series D Financing in Rivermark Medical
May 13, 2026

Andera Partners Leads $20 Million Series D Financing in Rivermark Medical

Indeterminate GlobeNewswire
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
May 13, 2026

Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Indeterminate GlobeNewswire
Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 13, 2026

Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026

Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Wellness Daily Nauru

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.